Legal
Moolenaar Targets $15.2B BMS Deal in China Crackdown
If Treasury acts on Moolenaar's COINS Act request, deals like BMS's $15.2B Hengrui partnership would need federal clearance before closing.
Latest — Page 17
Legal
Fed Proposes FinTech Payment Accounts Capped at $1B
The Fed's new payment account category hands FinTechs direct settlement access while stripping interest, discount window, and intraday credit.
FDA
Ousted: RFK Jr. Ends Makary's 13-Month FDA Tenure
Makary's 13 months at the FDA ended May 12 over a flavored-vape standoff, with food deputy Kyle Diamantas now acting commissioner.
Legal
FDIC Files Third GENIUS Act Rule: BSA for Stablecoins
FDIC's third GENIUS Act NPRM adds AML/CFT rules to stablecoin issuers, completing a compliance stack that changes who can enter the market.
Legal
Trump Mobile Exposed Customer Data, Stalls on Notification
Trump Mobile confirmed a customer data exposure linked to a third-party provider, then said it's still weighing whether to notify those affected.
Legal
C.A. Cloud Execs Plead Guilty to Tech Fraud Cover-Up
C.A. Cloud's CEO and CSO pleaded guilty to concealing a five-year fraud scheme that funneled calls to scammers targeting elderly victims worldwide.
Legal
FTC Hits Cox Media With $880K for Fake AI Ads
Cox Media Group's "Active Listening" AI never used voice data; the FTC's $880K settlement shows it was email lists at markup. Small businesses paid.
FDA
CHMP Backs Camizestrant After ODAC's 3-6 No Vote
CHMP backed camizestrant for ER+/HER2- breast cancer as ODAC voted 3-6 against. Europe and the US disagree on trial design, not the drug's efficacy.
FDA
Gilead Wins Hepcludex Nod Four Years After FDA Rejection
Gilead's Hepcludex wins US approval four years after a manufacturing CRL, becoming the first treatment for HDV in a market of up to 80,000 patients.
FDA
FDA Clears Datroway First-Line TNBC
FDA cleared Datroway May 22 for first-line metastatic TNBC, backed by a $1B upfront AZ bet and a $5B peak sales target, first to beat chemo on OS.
SEC
Goldman Paid $500M to End 1MDB Shareholder Suit
Goldman's $500M shareholder settlement adds to a $7.5B total 1MDB bill, or 12x the $600M in fees the bank collected for that deal.
SEC
CFPB Narrows 1071 to $1M Threshold, 2028 Deadline
The CFPB's revised 1071 Rule cuts the small-business revenue ceiling to $1M, drops key demographic data, and pushes compliance to 2028.
Deals
Filed: CVC, GBL Bid €10.7B to Delist Recordati
CVC and GBL bid €10.7B to take Recordati private, but a 13% premium to the March price is a thin ask when you already control the register.
FDA
Ousted: Biohaven Ran the Campaign Against Makary
Biohaven's CEO and other biotech leaders quietly lobbied the White House to push out FDA's Makary after troriluzole's November CRL.
Deals
EU Reviews MiCA Two Years In; Dollar Stablecoins Win
Europe's flagship crypto framework is barely two years old, and Brussels is already asking if it can survive dollar stablecoins' global grip.
